A groundbreaking victory has been reached in the fight against malaria. Novartis announced today that its revolutionary therapy has received formal approval to address malaria in newborns and infants, marking a major advancement in global health. This cutting-edge pharmaceutical will now be available for countries where malaria is most prevalent,